VEGF-B in islet of langerhans : role in vascular signaling and lipid handling by Ning, Frank Chenfei




VEGF-B IN ISLETS OF LANGERHANS: 










































VEGF-B IN ISLETS OF LANGERHANS: ROLE IN 
VASCULAR SIGNALING AND LIPID HANDLING 
 
THESIS FOR DOCTORAL DEGREE (Ph.D.) 
Public Defense at Karolinska Institutet  
Lecture Hall Inghesalen, Widerströmska Huset, Tomtebodavägen 18A, Solna  
Friday 6th March, 2020 at 9:30 
By 
Frank Chenfei Ning 
Principal Supervisor: 
Dr. Daniel Nyqvist  
Karolinska Institutet 
Department of Medical Biochemistry and 
Biophysics 
Division of Vascular Biology 
 
Co-supervisor(s): 
Dr. Ingrid Nilsson 
Karolinska Institutet 
Department of Medical Biochemistry and 
Biophysics  
Division of Vascular Biology 
 
Professor Ulf Eriksson  
Karolinska Institutet 
Department of Medical Biochemistry and 
Biophysics 
Division of Vascular Biology 
Opponent: 
Professor Peter Bergsten 
Uppsala University  




Docent Peetra Magnusson 
Uppsala University 
Department of Immunology, Genetics and 
Pathology 
 
Docent Mats Hellström 
Uppsala University  
Department of Immunology, Genetics and 
Pathology 
 
Docent Christina Bark 
Karolinska Institutet 
Department of Molecular Medicine and Surgery 
 













To my dear grandmother and 
In loving memory of my grandfather  



















LIST OF SCIENTIFIC PAPERS 
 
 
I. Frank Chenfei Ning, Nina Jensen, Jiarui Mi, William Lindström, Mirela 
Balan, Lars Muhl, Ulf Eriksson, Ingrid Nilsson & Daniel Nyqvist.  
VEGF-B ablation in pancreatic β-cells upregulates insulin expression without 
affecting glucose homeostasis or islet lipid uptake. 
Scientific Reports 10, 923 (2020) doi.org/10.1038/s41598-020-57599-2 
 
 
II. Frank Chenfei Ning, Mirela Balan, Jiarui Mi, Ulf Eriksson, Ingrid Nilsson & 
Daniel Nyqvist. 
Overexpression of VEGF-B in pancreatic β-cells does not affect glucose 




III. Mirela Balan, Marta Trusohamn, Frank Chenfei Ning, Stefan Jocob, Kristian 
Pietras, Ulf Eriksson, Per-Olof Berggren & Daniel Nyqvist.  
Noninvasive intravital high-resolution imaging of pancreatic neuroendocrine 
tumours.  
Scientific Reports 9, 14636 (2019) doi:10.1038/s41598-019-51093-0 
 
 
IV. Agnieszka Martowicz, Marta Trusohamn, Nina Jensen, Joanna Wisniewska-
Kruk, Monica Corada, Frank Chenfei Ning, Julianna Kele, Elisabetta Dejana 
& Daniel Nyqvist.  
Endothelial β-Catenin Signaling Supports Postnatal Brain and Retinal 
Angiogenesis by Promoting Sprouting, Tip Cell Formation, and VEGFR 
(Vascular Endothelial Growth Factor Receptor) 2 Expression.  
Arteriosclerosis, Thrombosis, and Vascular Biology, 39, 2273-2288 (2019). 
doi:10.1161/ATVBAHA.119.312749 
  





























1. VASCULAR ENDOTHELIAL GROWTH FACTOR B 
 
 
1.1 Biology, Tissue Distribution and Regulation of VEGF-B  
1.1.1 The Biology of VEGF-B 
 2 
 
Figure 1. Schematic diagram of VEGF ligands and receptors 
Partially overlapping binding pattern of VEGF ligands to their receptors. VEGF-A, VEGF-B and 















1.2 Role in Angiogenesis, Fatty Acid Uptake and Metabolism 
1.2.1 Role of VEGF-B in Angiogenesis  
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1.2.2 Fatty Acid Uptake and Metabolism 
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Figure 2. Schematic illustration of VEGF-B in trans-endothelial FA transport 
1: VEGF-B and mitochondrial proteins under the control of PGC1 are co-expressed in tissue cells to 
co-ordinate endothelial fatty acid transcytosis and tissue β-oxidation. 2: VEGF-B signals via VEGFR1 
and NRP1 on the endothelial cells in a paracrine fashion. 3: Stimulation of endothelial cells with VEGF-
B upregulates vascular FATPs expression and induces transport of fatty acids cross the endothelial layer 
















2. ISLETS OF LANGERHANS AND LIPIDS 
 
 
2.1 Islet Anatomy, Biology and Vasculature   
2.1.1 The Anatomy and Biology of Islets of Langerhans 
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2.2 Lipid Transport and Islets of Langerhans 





2.2.2 Lipid Transport in Pancreatic Islets  
 13 
 
2.2.3 Lipid Signaling in Pancreatic Islets  
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Figure 3. Schematic diagram of fatty acid uptake into pancreatic β-cells and potential 
consequence 
Palmitate (PA) transmembrane transport by CD36 results in formation of increased ceramide and 
formation of lipid droplets (LD), which trigger cell stress responses, such as ER stress, 
mitochondrial dysfunction and defective autophagy. PA also activates FFA receptors resulting in 




2.3 Lipotoxicity in Pancreatic Islets  
2.3.1 ER Stress 
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3. ISLET INTRAVITAL IMAGING 
 
 
3.1 Development and History  
 19 
 
Figure 4. Graphic illustration of noninvasive intravital imaging technique  
1. Isolation of tumorigenic RT2 islets. 2. Transplantation of isolated RT2 islets into the anterior 
chamber of the eye. 3. Weekly multiphoton/confocal intravital imaging of islet tumor 
progression.   (Modified image from Balan et. al, Scientific Reports, 20192) 
 











4. ENDOTHELIAL Wnt/-Catenin SIGNALING 
 
 
























RESULTS AND DISCUSSION 
 
Study I. VEGF-B ablation in pancreatic β-cells upregulates insulin expression 
without affecting glucose homeostasis or islet lipid uptake  
VEGF-B is ubiquitously expressed in pancreas 
 25 
 
Deficiency of Vegfb in pancreatic β-cells results in increased insulin gene 
expression  
β-cell specific Vegfb deficiency does not affect islet function or glucose 
homeostasis under chow and HFD diet condition  
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Pancreatic islet VEGF-B expression is not affected by increased metabolic 




Study II. Overexpression of VEGF-B in pancreatic β-cells does not affect glucose 
homeostasis but increases plasma triglycerides 
2,21,53,54,56,191




Systemic glucose homeostasis is not affected by VEGF-B overexpression in 
pancreatic -cells  
Transgenic overexpression of VEGF-B in pancreatic β-cells increases plasma 
triglycerides 
 




Pancreatic neuroendocrine tumor characterization 
Sunitinib treatment resulted in tumor regression and reduced tumor growth 
 30 
 
Overexpression of VEGF-B reduces tumor growth but increases tumor 
angiogenesis  
Study IV. Endothelial β-catenin signaling supports postnatal brain and retinal 
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